Multiple myeloma rates increasing twice as high in men than in women
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and…
Antibody Therapy Eradicates Traces of Multiple Myeloma in Preliminary Trial
By: Wynne Parry | December 06, 2025 | 7 min. read | Share Summary Sylvester Comprehensive Cancer Center researchers…
Genomic clues uncover early origins of multiple myeloma
A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood…
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
Maura, F. et al. Moving from cancer burden to cancer genomics for smoldering myeloma: a review. JAMA Oncol.…